| 1 |
Chen W, Zheng R, Zeng H, et a1. Annual report on status of cancer in China, 2011[J]. Chin J Cancer Res, 2015, 27:2-12.
|
| 2 |
Preusser M, Capper D, llhan-Mutlu A, et a1. Brain metastases: pathobiology and emerging targeted therapies[J]. Acta Neuropathol, 2012,123(2):205-222．
|
| 3 |
Soffietti R, Cornu P, Delattre JY, et al. EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force[J]. Eur J Neurol, 2006,13(7):674-681.
|
| 4 |
Liu W, Zhao J, Wei Y. Association between brain metastasis from lung cancer and the serum level of myelin basic protein[J]. Exp Ther Med, 2015,9:1048-1050.
|
| 5 |
Vogelbaum MA, Masaryk T, Mazzone P, et al. S100 β as a predictor of brain metastases: Brain versus cerebrovascular damage[J]. Cancer, 2005,15:104(4):817-824.
|
| 6 |
Pang X, Min J, Liu L, et al. S100B protein as a possible participant in the brain metastasis of NSCLC[J]. Med Oncol, 2012,29(4):2626-2632.
|
| 7 |
Mir S, Ali F, Chauhan D, et al. Accumulation of reactivity to MBP sensitizes TRAIL mediated oligodendrocyte apoptosis in adult sub cortical white matter in a model for human multiple sclerosis[J]. Metab Brain Dis, 2016,31(2):299-309.
|
| 8 |
Nagdyman N, Komen W, Ko HK, et al. Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia[J]. Pediatr Res, 2001,49(4):502-506．
|
| 9 |
Núñez C, Lozada-Requena I, Ysmodes T, et al. Immunomodulation of Uncaria tomentosa over dendritic cells, il-12 and profile TH1/TH2/TH17 in breast cancer[J]. Rev Peru Med Exp Salud Publica, 2015,32(4):643-651.
|
| 10 |
Rizzo A, De Mare V, Rocchi C, et al. Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells[J]. Carcinogenesis, 2014,35(7):1536-1546.
|
| 11 |
He G1, Zhang B, Zhang B, et al. Th17 cells and IL-17 are increased in patients with brain metastases from the primary lung cancer[J]. Zhongguo Fei Ai Za Zhi, 2013,16(9):476-481.
|
| 12 |
Noris-Garcia E, Eseobar-Perez X. Brain metastasis and the carcinoembryonic antigen[J]. Rev Neurol, 2004,38(3):267-270．
|
| 13 |
Lee DS, Kim YS, Jung SL, et a1. The relevance of serum carcinoembryonic antigen as an indicator of brain metastasis detection in advanced non-small cell lung cancer[J]. Tumour Biol, 2012,33(4):1065-1073.
|
| 14 |
Janowski M. Functional diversity of SDF-1 splicing variants[J]. Cell Adh Migr, 2009,3(3):243-249.
|
| 15 |
Chen G, Wang Z, Liu XY, et al. High-level Cxcr4 expression correlates with brain-specific metastasis of non-small cell lung cancer[J]. World J Surg, 2011,35(1):56-61.
|
| 16 |
Salmaggi A, Maderna E, Calatozzolo C, et al. CXCL2, CXCR4 and CXCR7 expression in brain metastases[J]. Cancer Biol Ther, 2009,8(17):1608-1614.
|
| 17 |
Ma S, Liu X, Geng JG, et al. Increased SLIT immunoreactivity as a biomarker for recurrence in endometrial carcinoma[J]. Am J Obstet Gynecol, 2010,202(1):68.e1-68.e11.
|
| 18 |
李晓霞，金玲，孙增峰, 等. Robo1蛋白在非小细胞肺癌和肺癌脑转移组织中的表达及意义[J]. 中华肿瘤杂志, 2013,35(3):198-201.
|
| 19 |
解刚强，刘德纯，陈登庭, 等. 转化生长因子-βl诱导的半胱氨酰天冬氨酸特异性蛋白酶依赖的人胃癌细胞凋亡途径[J]. 中华实验外科杂志, 2012,29(8):1553-1555．
|
| 20 |
姜冠潮，廖贻达，李晓, 等. 半胱氨酰天冬氨酸特异性蛋白酶-8对非小细胞肺癌脑转移的预测价值[J]. 中华实验外科杂志, 2014,31(12):2894-2896.
|
| 21 |
Wang HM, Wang J. Expression of Tiam1 in lung cancer and its clinical significance[J]. Asian Pac J Cancer Prev, 2012,13(2):613-615.
|
| 22 |
Li YM, Qi WJ, Shen H. Quantitative analysis of Tiam1 expression in lung cancer and its clinical significance[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2011,31(10):1774-1777.
|
| 23 |
Weng MX, Wu CH, Yang XP. Expression and significance of E-cadherin, CD44V6, and proliferating cell nuclear antigen in non-small cell lung cancer[J]. Chin J Cancer, 2008,27(2): 191-195.
|
| 24 |
Yoo JY, Yang SH, Lee JE, et al. E-cadherin as a predictive marker of brain metastasis in non-small-cell lung cancer, and its regulation by pioglitazone in a preclinical model[J]. J Neurooncol, 2012,109(2):219-227.
|
| 25 |
Xu H, Tian Y, Yuan X, et al. Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis[J]. Onco Targets Ther, 2016,9:431-444.
|
| 26 |
Chen QY, Yan J, Hu HZ, et al. Expression of ezrin in human non-small cell lung cancer and its relationship with metastasis and prognosis[J]. Zhonghua Zhong Liu Za Zhi, 2012,34(6):436-440.
|
| 27 |
Baek MY, Ahn HK, Park KR, et al. Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer[J/OL]. Korean J Intern Med, 2015.158.[2016-04-20]. published online ahead of print April 20, 2016]
URL
|
| 28 |
皮新苗，李泽宇，马怡然, 等. MIP-1a诱导肺癌脑转移患者CIK细胞跨内皮迁移的研究[J]. 中国医科大学学报, 2016,45(2):141-149.
|
| 29 |
Shintani Y, Higashiyama S, Ohta M, et a1. Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis[J]. Cancer Res, 2004,64(12):4190-4196.
|
| 30 |
GaoY, Li G, Sun L, et al. ACTN4 and the pathways associated with cell motility and adhesion contribute to the process of lung cancer metastasis to the brain[J]. BMC Cancer, 2015,15:277.
|
| 31 |
Wu C, Asokan SB, Berginski ME, et a1. Arp2/3 is critical for lamellipodia and response to extracellular matrix cues but is dispensable for chemotaxis[J]. Cell, 2012,148(5):973-987.
|
| 32 |
Zhao H, Xie C, Lin X, et al. Coexpression of IQ-domain GTPase-activating protein 1 (IQGAP1) and Dishevelled (Dvl) is correlated with poor prognosis in non-small cell lung cancer[J]. PLoS One, 2014,9(12):e113713.
|
| 33 |
Pishko GL, Muldoon LL, Pagel MA, et al. Vascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis[J]. Fluids Barriers CNS, 2015,12:5.
|